Targeting SEZ6L2 in Colon Cancer: Efficacy of Bexarotene and Implications for Survival
Huajun Zheng, Zheng Jianying, Yan Shen
This study investigates SEZ6L2's role in colon cancer, showing its overexpression as a prognostic biomarker and Bexarotene's ability to downregulate it, with context-dependent therapeutic effects.
Journal of Gastrointestinal Cancer · Jul 2, 2024Peer-reviewedBiochemistry